What evidence supports using ketofol (ketamine + propofol) for intravenous induction, and what are the recommended doses and contraindications?

Ketofol for Induction: Evidence-Based Recommendations

Ketofol (ketamine-propofol combination) can be used for induction of anesthesia with doses of 0.75 mg/kg ketamine + 1.5 mg/kg propofol, providing hemodynamic stability superior to propofol alone, though the 2018 ASA guidelines indicate this combination produces deeper sedation with increased risk of respiratory depression and hypoxemia compared to propofol monotherapy. 1

Recommended Dosing Regimens

For Induction

• Standard ketofol ratio: 1:2 (ketamine:propofol) mixed in single syringe
  • Ketamine 0.75 mg/kg + Propofol 1.5 mg/kg 2
  • Alternative: Ketamine 0.5-1 mg/kg + Propofol 1-2 mg/kg 3, 4
• Administration: Infuse slowly over 60 seconds to minimize respiratory depression 5
• Onset: Faster than propofol alone (150 seconds vs 205 seconds to adequate depth) 2

For Maintenance

• Infusion rate: 0.4 mg/kg/min total (0.2 mg/kg/min each drug) initially 6
• Titration: Adjust based on clinical response; typical maintenance 0.6-1.2 mg/kg/min total dose 7

Key Advantages Over Propofol Alone

Hemodynamic stability: The cardiostimulant effects of ketamine counterbalance propofol's cardiodepressant properties, maintaining blood pressure and heart rate 3, 4. This is particularly valuable in:

• Elderly patients (>50 years) 4
• Hemodynamically unstable patients
• Disaster/emergency conditions with limited IV access 6

Reduced injection pain: 10% incidence with ketofol vs 80% with propofol alone 2

Better airway conditions: 90% excellent jaw relaxation vs 76% with propofol 2, 8

Critical Safety Considerations

Respiratory Depression Warning

The ASA guidelines explicitly state that propofol combined with ketamine produces deeper sedation with more respiratory depression and greater frequency of hypoxemia compared to propofol alone 1. This mandates:

• Continuous monitoring of respiratory function throughout procedure 1
• Emergency airway equipment immediately available 5
• Maintain IV access until no longer at risk for cardiorespiratory depression 1
• Titrate carefully - allow sufficient time between doses for peak effect assessment 1

Apnea Risk

• Apnea duration may be prolonged (325-385 seconds) 8
• Ketamine does NOT significantly reduce propofol's apnea risk 3
• Assisted ventilation must be available 5

Contraindications (from FDA labels)

Ketamine 5:

• Conditions where blood pressure elevation is hazardous
• Severe cardiac disease
• History of chronic ketamine abuse (risk of genitourinary toxicity)

Propofol 9:

• Allergy to eggs, egg products, soybeans, or soy products
• Not recommended for obstetrics/cesarean sections
• Requires experienced practitioners for administration

Practical Pitfalls to Avoid

1. Do NOT use 100 mg/mL ketamine concentration IV without dilution - must dilute 1:1 with sterile water or normal saline 5

2. Premedication considerations:

   • Administer antisialagogue before ketamine to reduce secretions 5
   • Consider benzodiazepine to prevent emergence delirium 5
   • Premedication with acepromazine combinations reduces total ketofol requirements 7

3. Rapid administration error: Slow infusion over 60 seconds prevents respiratory depression and enhanced vasopressor response 5

4. Pediatric bradycardia: Concomitant fentanyl with propofol may cause serious bradycardia in children 9

Evidence Quality Assessment

The 2018 ASA guidelines 1 provide the highest-level guidance, noting that RCTs comparing propofol-ketamine combinations show:

• Category A3-B evidence: Deeper sedation with combination
• Category A3-H evidence: More respiratory depression and hypoxemia with combination
• Category A2-E evidence: Equivocal findings for most other outcomes

Recent high-quality studies 2, 8 from 2013 demonstrate superior insertion conditions and hemodynamic stability, but these focus on procedural sedation rather than general anesthesia induction.

Clinical Decision Algorithm

Use ketofol for induction when:

• Hemodynamic instability is a concern
• Elderly or cardiovascular risk patients
• Painful injection site is problematic
• Rapid recovery desired

Avoid ketofol monotherapy when:

• Other analgo-sedatives are readily available (per 2025 guideline for ICU patients) 10
• Uncontrolled hypertension or cardiac disease present
• Inadequate airway management capabilities

Monitor intensively for:

• Oxygen saturation (expect some desaturation)
• Blood pressure and heart rate
• Respiratory rate and adequacy
• Depth of sedation (risk of oversedation)